Показати скорочений опис матеріалу
dc.contributor.author | Bondar, V. | en |
dc.contributor.author | Chernyshova, K. | en |
dc.contributor.author | Kolomiets, S. | en |
dc.contributor.author | Klochko, V. | en |
dc.contributor.author | Vasilets, V. | en |
dc.contributor.author | Halynska, V. | en |
dc.contributor.author | Oliynyk, D. | en |
dc.date.accessioned | 2021-11-16T12:58:06Z | |
dc.date.available | 2021-11-16T12:58:06Z | |
dc.date.issued | 2019 | |
dc.identifier.citation | Prospects for the use of integrated assessment of gene-candidates polymorphisms in the management of arterial hypertension: let’s start / V. Bondar, K. Chernyshova, S. Kolomiets et al // European Heart Journal. 2019. Vol. 40, n. 1. P. 2169. | en |
dc.identifier.uri | https://repo.odmu.edu.ua:443/xmlui/handle/123456789/10379 | |
dc.description.abstract | Nowadays a large amount of data about the frequency of gene-candidates polymorphisms occurrence in patients with arterial hypertension (AH) have been accumulated. The using of single polymorphisms for diagnostic and prognostic purposes appeared to be not perspective. However multiple accumulation of gene-candidates polymorphisms in person is realized mostly in formation of AH. The purpose of the research was to compare the proportion of modified gene-candidates in a group of hypertensive patients with a similar group of non-hypertensive patients using the gene modification index (GMI) calculation for possible using in diagnostic and prevention of AH. | en |
dc.language.iso | en | en |
dc.subject | gene-candidates polymorphisms | en |
dc.subject | arterial hypertension | en |
dc.subject | diagnostic | en |
dc.subject | modified gene-candidates | en |
dc.title | Prospects for the use of integrated assessment of gene-candidates polymorphisms in the management of arterial hypertension: let’s start | en |
dc.type | Article | en |